Your Article Summary
Human genome sciences submits biologics license application to fda for abthrax
Human Genome Sciences, 05/22/09
Human Genome Sciences, Inc. announced that it has submitted a Biologics License Application to the U.S. Food and Drug Administration for its human monoclonal antibody drug ABthrax for the treatment of inhalation anthrax.
Today in Licensure/Accreditation...keeping you current
Receive free subspecialty "5-minute updates" via email
New ncqa disease management standards focus on measurement, quality improvement and transparency
National Committee for Quality Assurance (NCQA), 12/15/09
EDI Accrediting Firm Updates Criteria
HealthDataManagement, 12/09/09
Consumer Demand for H1N1 Information Highlights Importance of Accreditation for Health Call Centers
URAC News Releases, 12/07/09

See Latest Articles